Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 46.43% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 32.32%. Over the past 30 days, the price of BPMC has fallen by 29.32%. And in the last five days, it has fallen by -0.06%.
In terms of market performance, Blueprint Medicines Corp had a somewhat regular. The highest value for the stock in the past year was $128.24 on 06/05/25, while the lowest value was $73.04 on 04/09/25.
52-week price history of BPMC Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Blueprint Medicines Corp’s current trading price is -0.40% away from its 52-week high, while its distance from the 52-week low is 74.86%. The stock’s price range for this period has been between $73.04 and $128.24. The Healthcare sector company’s shares saw a trading volume of about 5.58 million for the day, which was higher than the average daily volume of 2.19 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Blueprint Medicines Corp (BPMC) has experienced a quarterly rise of 47.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.25B and boasts a workforce of 649 employees.
How Moving Averages and Trading Volume Data Work Together
BPMC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for BPMC stands at 2.08. Similarly, the long-term debt-to-equity ratio is also 1.72.
